HER2-specific chimeric antigen receptor-T cells for targeted therapy of metastatic colorectal cancer
Abstract Chimeric antigen receptor (CAR) - T cell therapy is a new class of cellular immunotherapies, which has made great achievements in the treatment of malignant tumors. Despite improvements in colorectal cancer (CRC) therapy, treatment of many patients fails because of metastasis and recurrence...
Guardado en:
Autores principales: | Jie Xu, Qingtao Meng, Hao Sun, Xinwei Zhang, Jun Yun, Bin Li, Shenshen Wu, Xiaobo Li, Hongbao Yang, Haitao Zhu, Michael Aschner, Michela Relucenti, Giuseppe Familiari, Rui Chen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a951c8fcb43d4002b7844f3a23348587 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Engraftment of donor mesenchymal stem cells in chimeric BXSB includes vascular endothelial cells and hepatocytes
por: Jones OY, et al.
Publicado: (2011) -
PRMT3 promotes tumorigenesis by methylating and stabilizing HIF1α in colorectal cancer
por: Xin Zhang, et al.
Publicado: (2021) -
P2X7 promotes metastatic spreading and triggers release of miRNA-containing exosomes and microvesicles from melanoma cells
por: Anna Pegoraro, et al.
Publicado: (2021) -
SLC25A1 promotes tumor growth and survival by reprogramming energy metabolism in colorectal cancer
por: Ying Yang, et al.
Publicado: (2021) -
Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2/HO-1 signalling pathway in KRAS mutant colorectal cancer
por: Jiawen Yang, et al.
Publicado: (2021)